Table 2.
Coefficient | Standardized coefficient | P value | |
Model 1, n=38 | |||
Fat-cell area (%) | 0.0031 | 0.451 | 0.022 |
BMI (kg/m2) | 0.0025 | 0.122 | 0.487 |
HOMA-IR | 0.0071 | 0.087 | 0.607 |
Model 2, n=29 | |||
Fat-cell area (%) | 0.0041 | 0.600 | 0.0027 |
BMI (kg/m2) | −0.0016 | −0.090 | 0.634 |
AUCglucose (min·mmol/L) | 0.0069 | 0.453 | 0.0042 |
Model 3, n=36 | |||
Fat-cell area (%) | 0.0028 | 0.425 | 0.021 |
BMI (kg/m2) | 0.0013 | 0.071 | 0.678 |
F-CPR (nmol/L) | 0.089 | 0.269 | 0.084 |
Model 4, n=28 | |||
Fat-cell area (%) | 0.0027 | 0.397 | 0.036 |
HOMA-IR | 0.019 | 0.226 | 0.216 |
AUCglucose (min·mmol/L) | 0.0067 | 0.442 | 0.0029 |
Model 5, n=32 | |||
Fat-cell area (%) | 0.0036 | 0.545 | 0.0060 |
HOMA-IR | −0.024 | −0.274 | 0.373 |
F-CPR (nmol/L) | 0.171 | 0.439 | 0.118 |
Model 6, n=24 | |||
Fat-cell area (%) | 0.0031 | 0.467 | 0.0093 |
AUCglucose (min·mmol/L) | 0.0064 | 0.421 | 0.0089 |
F-CPR (nmol/L) | 0.075 | 0.204 | 0.223 |
AUCglucose, area under the glucose concentration curve; BMI, body mass index; F-CPR, fasting C-peptide immunoreactivity; HOMA-IR, homeostasis model assessment insulin resistance.